Sandrine Ruiz

First‐in‐human study of the safety, tolerability, pharmacokinetics and pharmacodynamics of abediterol (LAS100977), a novel long‐acting Β₂‐agonist

Wolfgang Timmer, Èric Massana, Eulalia Jiménez et al. · The Journal of Clinical Pharmacology · 2014 · 18 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Abediterol (LAS100977), a novel long-acting β2-agonist: Efficacy, safety and tolerability in persistent asthma

Jutta Beier, Rainard Fuhr, Èric Massana et al. · Respiratory Medicine · 2014 · 14 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

A dose-ranging study of the bronchodilator effects of abediterol (LAS100977), a long-acting β2-adrenergic agonist, in asthma; a Phase II, randomized study

Dave Singh, Helena Pujol, Anna Ribera et al. · BMC Pulmonary Medicine · 2014 · 14 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Abediterol, a novel long-acting β2-agonist: bronchodilation, safety, tolerability and pharmacokinetic results from a single-dose, dose-ranging, active-comparator study in patients with COPD

Jutta Beier, Helena Pujol, Beatriz Seoane et al. · BMC Pulmonary Medicine · 2016 · 14 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Single Doses Of LAS100977, A Novel Long Acting ²2-agonist, Show High Activity And Long Duration In Healthy Subjects

Wolfgang Timmer, Èric Massana, Eulalia Jiménez et al. · 2010 · 10 citations

Medicine, Pharmacology, Pharmacotherapy +8